Global Intelligent Asthma Monitoring Devices Market Size study & Forecast, by Product (Wearable Asthma Monitoring Devices, Smart Inhalers, Nebulizers), By End-User (Hospitals, Homecare, Clinics) and Regional Analysis, 2023-2030

Global Intelligent Asthma Monitoring Devices Market Size study & Forecast, by Product (Wearable Asthma Monitoring Devices, Smart Inhalers, Nebulizers), By End-User (Hospitals, Homecare, Clinics) and Regional Analysis, 2023-2030

Global Intelligent Asthma Monitoring Devices Market is valued at approximately USD 282.48 million in 2022 and is anticipated to grow with a healthy growth rate of more than 25.1% over the forecast period 2023-2030. Intelligent asthma monitoring devices are innovative tools that use advanced technology to help individuals with asthma manage their conditions more effectively. These devices are designed to track and monitor various parameters related to asthma, such as lung function, symptoms, medication usage, and environmental triggers, to provide valuable insights and feedback for better asthma management. The Intelligent Asthma Monitoring Devices market is expanding because of factors such as growing geriatric population and surge in incidence of asthma cases. Intelligent asthma monitoring devices can also help users track their medication usage, including inhaler technique, frequency, and dosage. This can help individuals adhere to their prescribed medication regimen and avoid overuse or underuse of asthma medications, leading to better symptom control and reduced risk of asthma exacerbations. Its prevalence has progressively increased during the last few decades.

According to the World Bank Group, In 2020, the world's elderly population was 727 million, and it is expected to triple over the next three decades, reaching 1.5 billion in 2050. Furthermore, geriatric and obese populations are predisposed to chronic diseases. As per the Asthma and Allergy Foundation of America, asthma is common in adults aged 65 and older. Around 7.8% of older adults in the United States have asthma. Another important component driving space increase is rising incidence of asthma cases. As per Statista, the number of cases of asthma in senior citizens across India in 2050 was forecasted to be about 25.4 million. In addition, in 2020, in the United States, the highest percentage of current asthma was reported for the age group ranging from 15 to 34 years, with a total value of 8.9%. Also, increased focus toward advanced treatment protocols and rising healthcare expenditure. would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Intelligent Asthma Monitoring Devices stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Intelligent Asthma Monitoring Devices Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising investment in modern healthcare technologies and government support and funding for research & development. According to the American College of Allergy, Asthma & Immunology, in 2020, Asthma affects 8.3% of the American population, including 20.4 million adults and 6.1 million children. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric populations and increasing prevalence of asthma in the market space.

Major market players included in this report are:
AstraZeneca PLC
Cohero Health Inc
Glaxosmithkline PLC
Omron Corporation
Koninklijke Philips N.V
Reciprocal Labs Corporation
Teva Pharmaceuticals Industries Ltd
Vectura Group Plc
Volansys Technologies Pvt Ltd
Nihon Kohden Corporation

Recent Developments in the Market:
In April 2023 OMRON Corporation launched the NX-series NX502-1x00 CPU Units automation controllers with advanced information control and safety control, and the NX-EIP201 EtherNet/IP. The NX502 CPU Units and NX-EIP201 EtherNet/IP Units utilize the capabilities of OMRON's own advanced information processing, communications technologies, and large-capacity memory to achieve real-time analysis and process modularization which helps to reduce resource disposal losses at manufacturing locations and shorten lead times while changing lines.

Global Intelligent Asthma Monitoring Devices Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, End-User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product
Wearable Asthma Monitoring Devices
Smart Inhalers
Nebulizers

By End-User
Hospitals
Homecare
Clinics

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned

AstraZeneca PLC
Cohero Health Inc
Glaxosmithkline PLC
Omron Corporation
Koninklijke Philips N.V
Reciprocal Labs Corporation
Teva Pharmaceuticals Industries Ltd
Vectura Group Plc
Volansys Technologies Pvt Ltd
Nihon Kohden Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.